Factor XII/XIIa inhibitors: Their discovery, development, and potential indications

Titre traduit de la contribution: Inhibiteurs du facteur XII/XIIa : leur découverte, développement et indications potentielles

Résultats de recherche: Contribution à un journal/une revueArticle de revueRevue par des pairs

56 Téléchargements (Pure)

Résumé

Coagulation factor XII (FXII), a S1A serine protease, was discovered more than fifty years ago. However, its in vivo functions and its three-dimensional structure started to be disclosed in the last decade. FXII was found at the crosstalk of several physiological pathways including the intrinsic coagulation pathway, the kallikrein-kinin system, and the immune response. The FXII inhibition emerges as a therapeutic strategy for the safe prevention of artificial surface-induced thrombosis and in patients suffering from hereditary angioedema. The anti-FXII antibody garadacimab discovered by phage-display library technology is actually under phase II clinical evaluation for the prophylactic treatment of hereditary angioedema. The implication of FXII in neuro-inflammatory and neurodegenerative disorders is also an emerging research field. The FXII or FXIIa inhibitors currently under development include peptides, proteins, antibodies, RNA-based technologies, and, to a lesser extent, small-molecular weight inhibitors. Most of them are proteins, mainly isolated from hematophagous arthropods and plants. The discovery and development of these FXII inhibitors and their potential indications are discussed in the review.
Titre traduit de la contributionInhibiteurs du facteur XII/XIIa : leur découverte, développement et indications potentielles
langue originaleAnglais
Numéro d'article112753
journalEuropean Journal of Medicinal Chemistry
Volume208
Les DOIs
Etat de la publicationPublié - 1 déc. 2020

mots-clés

  • Serine proteinase inhibitors
  • Drug development
  • Antithrombotic agents
  • Anti-inflammatory agents
  • Contact pathway
  • Factor XII

Empreinte digitale

Examiner les sujets de recherche de « Inhibiteurs du facteur XII/XIIa : leur découverte, développement et indications potentielles: Their discovery, development, and potential indications ». Ensemble, ils forment une empreinte digitale unique.

Contient cette citation